Hydroxyprogesterone caproate
id:
hydroxyprogesterone-caproate-175-2291667
title:
Hydroxyprogesterone caproate
text:
Hydroxyprogesterone caproate, sold under the brand name Delalutin among others, is a medication used to reduce the risk of preterm birth in women pregnant with one baby who have a history of spontaneous preterm birth. In March 2023, the manufacturer, Covis Pharma, agreed to withdraw the drug from the US market. The approval of this drug substance was withdrawn by the US Food and Drug Administration (FDA) in April 2023. In May 2024, the Pharmacovigilance Risk Assessment Committee of the European
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Hydroxyprogesterone_caproate
date created:
2007-03-16T08:51:52Z
date modified:
2024-09-03T03:32:18Z
main entity:
{"identifier":"Q3792032","url":"https://www.wikidata.org/entity/Q3792032"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/7/71/Hydroxyprogesterone_caproate_molecule_ball.png","width":1640,"height":930}
fields total:
13
integrity:
16